Merrem IV - labeled renal guidance
Renal action and limits
Meropenem (Merrem IV), adult IV use for labeled infections
Cockcroft-Gault creatinine clearance, mL/min
This summary uses the identified dated label. Verify the current label for this presentation before applying the regimen.
- Action or finding
- Start with the usual dose for the infection. CrCl >50: usual dose every 8 hours. At 26-50: usual dose every 12 hours. At 10-25: half the usual dose every 12 hours. Below 10: half the usual dose every 24 hours.
- Limits and monitoring
- The FDA label has insufficient information for hemodialysis or peritoneal dialysis. Separate institutional regimens carry their own assumptions.
- Before use
- Verify the current prescribing information for this presentation.
- Product / population
- Meropenem (Merrem IV), adult IV use for labeled infections
- Renal measure
- Cockcroft-Gault creatinine clearance, mL/min
- Source revision
- Prescribing information revised 12/2024
- Retrieved
- 2026-11-07 (not the revision date)
Renal guidance: 2, adult patients with renal impairment
The FDA label has insufficient information for hemodialysis or peritoneal dialysis. Separate institutional regimens carry their own assumptions.
| CrCl (mL/min) | Fraction of usual indication dose | Interval |
|---|---|---|
| >50 | Full | Every 8 hours |
| 26-50 | Full | Every 12 hours |
| 10-25 | Half | Every 12 hours |
| <10 | Half | Every 24 hours |
Read the retained text before reformatting
Start with the usual dose for the infection. CrCl >50: usual dose every 8 hours. At 26-50: usual dose every 12 hours. At 10-25: half the usual dose every 12 hours. Below 10: half the usual dose every 24 hours. The FDA label has insufficient information for hemodialysis or peritoneal dialysis. Separate institutional regimens carry their own assumptions.
Source: https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/050706s044lbl.pdf
